106 related articles for article (PubMed ID: 28178415)
1. Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.
Sharma S; Kotamraju VR; Mölder T; Tobi A; Teesalu T; Ruoslahti E
Nano Lett; 2017 Mar; 17(3):1356-1364. PubMed ID: 28178415
[TBL] [Abstract][Full Text] [Related]
2. Tumor penetrating peptides for improved drug delivery.
Ruoslahti E
Adv Drug Deliv Rev; 2017 Feb; 110-111():3-12. PubMed ID: 27040947
[TBL] [Abstract][Full Text] [Related]
3. Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo.
Wonder E; Simón-Gracia L; Scodeller P; Majzoub RN; Kotamraju VR; Ewert KK; Teesalu T; Safinya CR
Biomaterials; 2018 Jun; 166():52-63. PubMed ID: 29544111
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells.
Haddad Y; Charousova M; Zivotska H; Splichal Z; Merlos Rodrigo MA; Michalkova H; Krizkova S; Tesarova B; Richtera L; Vitek P; Stokowa-Soltys K; Hynek D; Milosavljevic V; Rex S; Heger Z
J Nanobiotechnology; 2020 Jul; 18(1):95. PubMed ID: 32660596
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-induced vascular blockade in human prostate cancer.
Agemy L; Sugahara KN; Kotamraju VR; Gujraty K; Girard OM; Kono Y; Mattrey RF; Park JH; Sailor MJ; Jimenez AI; Cativiela C; Zanuy D; Sayago FJ; Aleman C; Nussinov R; Ruoslahti E
Blood; 2010 Oct; 116(15):2847-56. PubMed ID: 20587786
[TBL] [Abstract][Full Text] [Related]
6. The past, present, and future of breast cancer models for nanomedicine development.
Boix-Montesinos P; Soriano-Teruel PM; Armiñán A; Orzáez M; Vicent MJ
Adv Drug Deliv Rev; 2021 Jun; 173():306-330. PubMed ID: 33798642
[TBL] [Abstract][Full Text] [Related]
7. Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy.
Quijia CR; Enríquez AQ; Zappia CD; Peroni RN; Chorilli M
Curr Med Chem; 2024; 31(6):726-761. PubMed ID: 37291791
[TBL] [Abstract][Full Text] [Related]
8. Peptides as multifunctional players in cancer therapy.
Vadevoo SMP; Gurung S; Lee HS; Gunassekaran GR; Lee SM; Yoon JW; Lee YK; Lee B
Exp Mol Med; 2023 Jun; 55(6):1099-1109. PubMed ID: 37258584
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool.
Zhang Q; Yang Z; Zhang J; Li Y; Dang X; Qu J; Pan X; Zhang J
Bioorg Chem; 2024 Apr; 145():107240. PubMed ID: 38412651
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced amplification of nanoparticle targeting to tumors.
Lin KY; Kwon EJ; Lo JH; Bhatia SN
Nano Today; 2014 Oct; 9(5):550-559. PubMed ID: 29731806
[TBL] [Abstract][Full Text] [Related]
11. Correction to "Engineered Recombinant EGFP-Azurin Theranostic Nanosystem for Targeted Therapy of Prostate Cancer".
Bhardwaj R; Mishra P
Mol Pharm; 2024 Feb; 21(2):992. PubMed ID: 38270493
[No Abstract] [Full Text] [Related]
12. ADVANCED MULTIMODAL NANOSYSTEM : THE FUTURE MEDICINE.
Mandal S
Isci Notes; 2016; 1():. PubMed ID: 32095659
[No Abstract] [Full Text] [Related]
13. Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.
Hunt H; Simón-Gracia L; Tobi A; Kotamraju VR; Sharma S; Nigul M; Sugahara KN; Ruoslahti E; Teesalu T
J Control Release; 2017 Aug; 260():142-153. PubMed ID: 28603028
[TBL] [Abstract][Full Text] [Related]
14. Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment.
Sharma S; Mann AP; Mölder T; Kotamraju VR; Mattrey R; Teesalu T; Ruoslahti E
J Control Release; 2017 Dec; 268():49-56. PubMed ID: 29030222
[TBL] [Abstract][Full Text] [Related]
15. Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier.
Ruoslahti E
J Clin Invest; 2017 May; 127(5):1622-1624. PubMed ID: 28414298
[TBL] [Abstract][Full Text] [Related]
16. Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.
Scodeller P; Simón-Gracia L; Kopanchuk S; Tobi A; Kilk K; Säälik P; Kurm K; Squadrito ML; Kotamraju VR; Rinken A; De Palma M; Ruoslahti E; Teesalu T
Sci Rep; 2017 Nov; 7(1):14655. PubMed ID: 29116108
[TBL] [Abstract][Full Text] [Related]
17. Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti-Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections.
Kwon EJ; Skalak M; Bertucci A; Braun G; Ricci F; Ruoslahti E; Sailor MJ; Bhatia SN
Adv Mater; 2017 Sep; 29(35):. PubMed ID: 28699173
[TBL] [Abstract][Full Text] [Related]
18. In vivo cation exchange in quantum dots for tumor-specific imaging.
Liu X; Braun GB; Qin M; Ruoslahti E; Sugahara KN
Nat Commun; 2017 Aug; 8(1):343. PubMed ID: 28839238
[TBL] [Abstract][Full Text] [Related]
19. Cell-Penetrating Peptides: From Basic Research to Clinics.
Guidotti G; Brambilla L; Rossi D
Trends Pharmacol Sci; 2017 Apr; 38(4):406-424. PubMed ID: 28209404
[TBL] [Abstract][Full Text] [Related]
20. Differentially cleaving peptides as a strategy for controlled drug release in human retinal pigment epithelial cells.
Bhattacharya M; Sarkhel S; Peltoniemi J; Broadbridge R; Tuomainen M; Auriola S; Urtti A
J Control Release; 2017 Apr; 251():37-48. PubMed ID: 28213274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
